Metabolon

RegFile AB

Sahlgrenska Science Park

LINK Medical Research

Eli Lilly värvar toppforskaren Kaj Blennow – ska leda Alzheimerprojekt

Eli Lilly rekryterar Kaj Blennow, en av Sveriges och världens främsta forskare inom Alzheimers sjukdom, till en post som Vice President of Neuroscience Biomarker Development.

Meeting with focus on South Korea and Japan’s life sciences

Large, complex and exciting – this is how Britta Stenson, Business Sweden, describes the life science markets of Japan and South Korea, which took centre stage ...

Kompauto Nordic AB

Merck Life Science A/S

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm (2026)

Medicon Village Science Park

Hypothesis testing versus conspiracy theory

"How do you know what is a conspiracy theory and what is a reasonable, scientifically based conclusion?" In a column, Ingrid Lönnstedt reflects on this question.

Bio-Works

Large study on milk: Risky for women but not for men

The risk of ischemic heart disease (IHD) and acute myocardial infarction (MI) increased for women with milk intake levels higher than 2 glasses per day, while n...

Behov av polypkirurgi nästan utplånat i studie

Problemen med polyper hos patienter med kronisk bihåleinflammation minskade kraftigt i en studie som utvärderade Tezspire från Astra Zeneca och Amgen.

Ready-to-install solutions for the lab-on-a-chip

Design for manufacturing lab-on-a-chip devices Reducing time-to-market together

Xbrane enters licensing agreement with Indian generics giant

Swedish biosimilar developer Xbrane Biopharma and the Indian company Intas Pharmaceuticals have entered into a license and co-development agreement.

The stomach medication that became the biggest blockbuster of the 1990s

The omeprazole molecule was synthesised as early as 1979, but it took many years before the then Astra had an approved pharmaceutical. Once this happened, a tab...

Därför skyr Big Pharma Storbritannien – miljardinvesteringar fryses

Läkemedelsjättar har skrotat eller pausat investeringar för nära två miljarder pund i Storbritannien hittills i år. Ett ”alltmer utmanande” klimat för innovatio...

Novo Nordisk to invest billions in new quality control lab

Novo Nordisk has announced plans to invest 2.9 billion Danish kroner in order to establish a new quality control laboratory in Hillerød in northern Zealand, Denmark.

New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...

Festo AB

Extensive agreements signed at Scilifelab

Four agreements were signed between Swedish and Dutch life science players in connection with the Dutch state visit earlier this month.

Quotient Sciences Limited

600 million SEK for life science - "Should not be the country of moderation"

Sweden will prioritize excellence over breadth in research. This was made clear when the government presented the research proposition for the next four years.